Collectively, these data supported an inhibitory function of FLRT3 in soluble form, suggesting additional mechanisms of FLRT3-UNC5B T cell suppression, and potentially additional therapeutic modalities beyond cancer. The gene discussed is FLRT3; the disease is cancer.